776 results on '"Chen, Chiung-Mei"'
Search Results
2. Impact of comorbidities on relapsing rates of Neuromyelitis Optica Spectrum Disorders: Insights from a longitudinal study in Taiwan
3. Ganglioside-focused Glycan Array Reveals Abnormal Anti-GD1b Auto-antibody in Plasma of Preclinical Huntington’s Disease
4. Author Correction: Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity
5. Increased 18 F-FDG uptake in denervated muscles in a case of Parsonage-Turner syndrome
6. Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity
7. Myasthenia gravis and independent risk factors for recurrent infection: a retrospective cohort study
8. Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3
9. The Role of NRF2 in Trinucleotide Repeat Expansion Disorders
10. Neuroprotection effects of kynurenic acid-loaded micelles for the Parkinson’s disease models
11. Protective Effects of Coptis chinensis Rhizome Extract and Its Constituents (Berberine, Coptisine, and Palmatine) against α-Synuclein Neurotoxicity in Dopaminergic SH-SY5Y Cells
12. Diagnostic Potential of Alternations of Bile Acid Profiles in the Plasma of Patients with Huntington's Disease.
13. X-linked adrenoleukodystrophy caused by a novel mutation presenting with various phenotypes in a Taiwanese family
14. Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment
15. Identification of Blood Metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with Type 2 Diabetes Mellitus
16. LMDS-1, a potential TrkB receptor agonist provides a safe and neurotrophic effect for early-phase Alzheimer’s disease
17. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan
18. Characteristics of ischemic stroke and intracranial hemorrhage in patients with nephrotic syndrome
19. Novel compound VB-037 inhibits Aβ aggregation and promotes neurite outgrowth through enhancement of HSP27 and reduction of P38 and JNK-mediated inflammation in cell models for Alzheimer's disease
20. Persistence and adherence to rivastigmine in patients with dementia: Results from a noninterventional, retrospective study using the National Health Insurance research database of Taiwan
21. Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against α-synuclein toxicity
22. Investigating the Therapeutic Effects of Novel Compounds Targeting Inflammasome and IL-1β and IL-6 Signaling Pathways in Spinocerebellar Ataxia Type 3
23. Genetic and functional characters of GRN p.T487I mutation in Taiwanese patients with atypical parkinsonian disorders
24. Modeling Alzheimer’s Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation
25. Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease
26. Association of alcohol dehydrogenase and aldehyde dehydrogenase Polymorphism with Spontaneous Deep Intracerebral Haemorrhage in the Taiwan population
27. Investigating the functional consequences of expanded triplet repeat sequence in a mouse model of Huntington's Disease (HD)
28. Diagnostic and Therapeutic Challenges
29. Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
30. Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s Disease
31. Using ΔK280 TauRD Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy
32. Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
33. A Neuroprotective Action of Quercetin and Apigenin through Inhibiting Aggregation of Aβ and Activation of TRKB Signaling in a Cellular Experiment
34. Neuroprotection of Kynurenic Acid-Loaded Micelles for in Vitro and in Vivo Parkinson's Disease Models
35. Non-alcoholic Wernicke’s encephalopathy with cortical involvement and polyneuropathy following gastrectomy
36. Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model
37. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease
38. Association of genetic variants within HLA-DR region with Parkinson's disease in Taiwan
39. Association of RIT2 and RAB7L1 with Parkinson's disease: a case-control study in a Taiwanese cohort and a meta-analysis in Asian populations
40. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease
41. Increased 18 F-FDG uptake in denervated muscles in a case of Parsonage-Turner syndrome.
42. The potential of lactulose and melibiose, two novel trehalase-indigestible and autophagy-inducing disaccharides, for polyQ-mediated neurodegenerative disease treatment
43. Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model
44. Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease
45. Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein
46. Clinical Characteristics and Prognostic Factors of Non-Infectious Cerebral Venous Sinus Thrombosis
47. Medicinal herbs Oerianthe javanica (Blume) DC., Casuarina equisetifolia L. and Sorghum bicolor (L.) Moench protect human cells from [MPP.sup.+] damage via inducing FBX07 expression
48. Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity
49. Isorhamnetin Attenuated the Release of Interleukin-6 from β-Amyloid-Activated Microglia and Mitigated Interleukin-6-Mediated Neurotoxicity
50. Establishment of a new classification system for chronic inflammatory demyelinating polyneuropathy based on unsupervised machine learning
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.